An international symposium focused on RASopathies and their impact on patients and families.
Official title: 9th International RASopathies Symposium
Funded at Rasopathies Network USA · NIH-11166711 · Data updated 2026-11-12
This study is all about bringing together experts, families, and advocates to share ideas and learn more about RASopathies, which are genetic conditions caused by issues in a specific signaling pathway, so everyone can work together to improve understanding and treatment options for those affected.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rasopathies Network USA NIH-funded |
| Lab location | 1 site (Altadena, United States) |
| Project start | June 1, 2025 |
| Project end | May 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $10,000 |
| NIH project number | 1R13TR005697-01 |
| Project ID | NIH-11166711 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children under 11 years old diagnosed with RASopathies or their families seeking support and information.
✕Less likely to help
Patients with conditions unrelated to RASopathies or those outside the age range may not benefit from this research.
What this research studies
This research involves organizing the 9th International RASopathies Symposium, which will bring together experts, advocates, and families to discuss congenital syndromes caused by the RAS-RAF-MEK-ERK signaling pathway. The symposium will feature scientific sessions that focus on understudied organ systems and will encourage cross-disciplinary discussions that include patient perspectives. By fostering collaboration among researchers and advocates, the symposium aims to advance understanding and treatment options for RASopathies.
Why it matters
Potential benefit: If successful, this research could lead to improved insights and treatment strategies for patients with RASopathies.
How similar studies have gone: Previous symposiums and collaborative efforts in rare disease research have shown success in advancing understanding and treatment options.
Where this research is happening
-
Rasopathies Network USA
Altadena, United States Active
Researchers
- Principal investigator: Schoyer, Lisa — Rasopathies Network USA
- Study coordinator: Schoyer, Lisa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.